Importantly, BGE-102 is an oral candidate. The current leaders in the anti-obesity market are administered via subcutaneous ...
Novartis AG agreed to buy Avidity Biosciences Inc. in a $12 billion deal that’s the Swiss drugmaker’s biggest acquisition in ...
Biotechnology's rapid development of the future of medicine shows little sign of slowing down. We speak to the International ...
Investors looking for stocks that can produce eye-popping gains in a short time frame often turn toward biotechnology stocks.
Regenerative Medicine in India is revolutionising healthcare through stem cell therapy, gene editing, and tissue engineering, ...
King Faisal Specialist Hospital & Research Centre (KFSHRC) has begun in-house manufacturing and clinical use of CAR-T cell ...
Fred Ramsdell, a Bainbridge resident for three decades, was part of a three-person team honored earlier in October.
Moderna’s market value has fallen by more than 90% — $185 billion, or a full Sony — from its 2021 peak to around $10 billion ...
The U.S. Food and Drug Administration is preparing to accelerate approvals for biosimilars, or generic versions of complex ...
A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...
Khaleej Times on MSN
Abu Dhabi-based Titian acquires stake in Swedish biotech firm
Titian Life Sciences is pursuing a multimodal approach to precision medicine and healthy ageing, integrating biotechnology, ...
23don MSN
How a scrappy biotech startup backed by Microsoft’s co-founders set the stage for two Nobel winners
The groundbreaking immunology research behind two Nobel Prizes awarded this week traces back to a largely forgotten biotech startup backed by Microsoft's co-founders.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results